CollimateHealth
Develops compact cancer-treatment technology aimed at reducing football-stadium-scale machines to systems occupying about 10 square metres.
Overview
CollimateHealth is building compact cancer-treatment equipment designed to shrink infrastructure described as football-stadium-scale into a footprint of about 10 square metres. The company targets cancer-care settings where the size and complexity of existing machines can limit deployment. The venture’s stated differentiator is miniaturization of a large cancer machine into a much smaller format. CollimateHealth raised €6 million in an undisclosed round backed by HTGF and four other venture investors.
Funding History
HTGF and four VCs back CollimateHealth’s €6M moonshot to shrink a football-stadium cancer machine to 10 square metres
Frequently Asked Questions
- How much funding does AI Funding track for CollimateHealth?
- AI Funding tracks €6M for CollimateHealth across 1 funding round in this database.
- Who are CollimateHealth's investors?
- CollimateHealth's investors include VP Venture Partners, High-Tech Gründerfonds, XISTA Science Ventures, Positron, caesar.
- What does CollimateHealth do?
- CollimateHealth is building compact cancer-treatment equipment designed to shrink infrastructure described as football-stadium-scale into a footprint of about 10 square metres. The company targets cancer-care settings where the size and complexity of existing machines can limit deployment. The venture’s stated differentiator is miniaturization of a large cancer machine into a much smaller format. CollimateHealth raised €6 million in an undisclosed round backed by HTGF and four other venture investors.
- Where is CollimateHealth headquartered?
- CollimateHealth is headquartered in San Francisco, CA.